ANTISENSE THERAPEUTICS LIMITED has not announced any capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Loading...
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Type
Listed Company
GICS Sub-industry
Pharmaceuticals
Head Office
6 Wallace Ave, Toorak VIC 3142, Australia
Website
Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED quarterly cash flows data.
Loading...
Loading...